Ensayos clínicos

8.676 ensayos encontrados

ReclutandoClinicalTrials.gov

Study of the Role of Genetic Modifiers in Hemoglobinopathies

OBSERVATIONALInicio: 1 de oct de 2022ID: NCT05799118

ReclutandoFase 3ClinicalTrials.gov

Efficacy and Safety of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

INTERVENTIONALInicio: 5 de abr de 2023ID: NCT05692180

ReclutandoFase 2ClinicalTrials.gov

A Long-Term Extension Study to Evaluate Safety and Efficacy of Verekitug (UPB-101) in Adult Participants With Severe Asthma Who Completed the VALIANT Trial

INTERVENTIONALInicio: 21 de may de 2025ID: NCT06966479

ReclutandoFase 3ClinicalTrials.gov

CLEOPATTRA: Effects of NNC6019-0001 Versus Placebo on Cardiovascular Outcomes in Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

INTERVENTIONALInicio: 2 de oct de 2025ID: NCT07207811

ReclutandoFase 2ClinicalTrials.gov

A Phase IIb Randomized, Double-blind, Placebo-controlled, Parallel, Multidose Study to Evaluate the Efficacy, Safety, and PK of AZD0292 in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

INTERVENTIONALInicio: 6 de nov de 2025ID: NCT07088926

ReclutandoClinicalTrials.gov

Monitoring of Breathing Effort Through Pressure Time Product Measurement Using Airway Occlusion Pressure

OBSERVATIONALInicio: 1 de oct de 2023ID: NCT06040138

ReclutandoFase 2ClinicalTrials.gov

A Phase II, Open-Label, Multicenter Study Evaluating the Safety and Efficacy of Neoadjuvant Treatment With Inavolisib Combinations in Patients With Untreated, Early-stage, PIK3CA-Mutated Breast Cancer

INTERVENTIONALInicio: 9 de sept de 2025ID: NCT07054190

ReclutandoClinicalTrials.gov

A Study to Evaluate the Accuracy of Primary Care Diagnosis Using Oscillometry and Fractional Exhaled Nitric Oxide for Asthma and COPD Versus Specialist Diagnosis in Patients With Suspected Asthma or COPD

OBSERVATIONALInicio: 26 de dic de 2025ID: NCT07245576

ReclutandoClinicalTrials.gov

A Registry to Collect Characteristics and Outcomes From Patients With Solid Tumors Profiled With a Next-Generation Sequencing Test (WAYFIND-R)

OBSERVATIONALInicio: 27 de ago de 2020ID: NCT04529122

ReclutandoFase 3ClinicalTrials.gov

A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Astegolimab in Patients With Chronic Obstructive Pulmonary Disease

INTERVENTIONALInicio: 29 de dic de 2022ID: NCT05595642

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-3)

INTERVENTIONALInicio: 2 de dic de 2025ID: NCT06937229

ReclutandoClinicalTrials.gov

EEG Alpha Rhythm Modulation Using Sham Neurofeedback During Attentional Control in a Virtual Reality Environment

OBSERVATIONALInicio: 1 de jul de 2025ID: NCT06748976

ReclutandoFase 3ClinicalTrials.gov

A Randomized, Double Blind, Multicenter Phase 3 Trial of BMS-986489 (BMS-986012+Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide vs Atezolizumab in Combination With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

INTERVENTIONALInicio: 25 de feb de 2025ID: NCT06646276

ReclutandoFase 2ClinicalTrials.gov

A Single-arm Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Lunsekimig in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Clinical Study

INTERVENTIONALInicio: 12 de may de 2025ID: NCT06914908

ReclutandoFase 3ClinicalTrials.gov

A Phase III, Multicenter, Double-Blind, Placebo-Controlled, Treat-Through Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With RO7790121 in Patients With Moderately to Severely Active Crohn's Disease

INTERVENTIONALInicio: 17 de mar de 2025ID: NCT06819878

ReclutandoFase 3ClinicalTrials.gov

AN OPEN-LABEL, RANDOMIZED, CONTROLLED PHASE 3 STUDY OF SIGVOTATUG VEDOTIN IN COMBINATION WITH PEMBROLIZUMAB COMPARED WITH PEMBROLIZUMAB MONOTHERAPY AS FIRST-LINE TREATMENT IN PARTICIPANTS WITH PD-L1 HIGH (≥50% OF TUMOR CELLS EXPRESSING PD-L1), LOCALLY ADVANCED, UNRESECTABLE, OR METASTATIC NON-SMALL CELL LUNG CANCER (BE6A LUNG-02)

INTERVENTIONALInicio: 23 de jul de 2025ID: NCT06758401

ReclutandoClinicalTrials.gov

Assessing the Usefulness of Functional Electrical Stimulation Program on Tibial Nerve for Rehabilitation of Chronic Stroke Patients

INTERVENTIONALInicio: 21 de mar de 2022ID: NCT05240716

ReclutandoFase 3ClinicalTrials.gov

A Phase 3, Randomized, Placebo-Controlled, Double-Blinded Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Multivalent Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants

INTERVENTIONALInicio: 25 de ago de 2025ID: NCT07160244

ReclutandoClinicalTrials.gov

Establishment and Exploitation of a European-Latin American Research Consortium Towards Eradication of Preventable Gallbladder Cancer - EULAT Eradicate GBC

OBSERVATIONALInicio: 1 de dic de 2019ID: NCT06192719

ReclutandoFase 3ClinicalTrials.gov

A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus Adjuvant Chemotherapy Versus Placebo Plus Adjuvant Chemotherapy in Stage IB-IIIA NSCLC Patients With Uncommon EGFR Mutations Following Complete Tumor Resection (REZILIENT4)

INTERVENTIONALInicio: 22 de dic de 2025ID: NCT07128199